Background: Asymptomatic variant haemoglobin is increasingly being found in the measurement of glycated haemoglobin (HbA 1c ) for the management of diabetes mellitus. We compared the HbA 1c concentrations measured by high-performance liquid chromatography (HPLC) and immunoassay and glycated albumin (GA) concentrations and calculated the respective ratios in order to classify the variant haemoglobin. Methods: Twenty different haemoglobin variants from 43 subjects were identified by mass spectrometry and DNA analysis. Since GA accurately reflects glycaemic control in patients with variant haemoglobin, we calculated respective ratios of HbA 1c and GA. Haemoglobin variants causing a low ratio of HbA 1c measured by HPLC (HPLC-HbA 1c ) to GA with a normal ratio of HbA 1c measured by immunoassay (IA-HbA 1c ) to GA were classified as C1. A further classification of a and b was used with abnormalities of the a chain or b chain in the haemoglobin gene. Other haemoglobin variants were classified as non-C1. Eight diabetic patients with stable glycaemic control were used as controls. 
Introduction
Variant haemoglobin results from mutations of amino acids in haemoglobin. A total of 1128 variant forms have been reported worldwide as of December 2011. 1 About 20% of the variants produce clinical phenotypes such as haemolytic anaemia, polycythaemia and metohaemoglobinaemia, while the remaining 80% demonstrate no abnormal phenotype. Although variant forms of haemoglobin have traditionally been found in patients with haematological diseases, asymptomatic forms are often found in the measurement of glycated haemoglobin (HbA 1c ) for the management of diabetes mellitus. 2 -4 Currently, highperformance liquid chromatography (HPLC) is most used to measure HbA 1c , since the technique is more accurate and reliable than other methods. In patients with variant haemoglobin, their HbA 1c concentrations measured by HPLC (HPLC-HbA 1c ) are higher or lower than the actual levels corresponding to glycaemia, leading to misjudgement of the glycaemic control status. In contrast, HbA 1c measured by immunoassay (IA-HbA 1c ) usually is not influenced by variant forms of haemoglobin, and this method is recommended for distinguishing the majority of variant haemoglobin and making decisions about their glycaemic control state. 5 However, variant forms of haemoglobin in which the lifespan of red blood cells is shortened or glycation is increased or decreased have been reported. 6 With these variant haemoglobins, even IA-HbA 1c sometimes yields abnormal results.
Glycated albumin (GA), another glycaemic control marker, is considered to accurately reflect glycaemic control in patients with variant haemoglobin. 7 Through calculation of the ratio of HPLC-HbA 1c or IA-HbA 1c to GA (HPLC-HbA 1c /GA or IA-HbA 1c /GA), it is possible to judge the discrepancy between HbA 1c levels and glycaemic control state because the HbA 1c /GA ratio is not influenced by glycaemic control state. 8, 9 Furthermore, no classification schemes have been set for variant haemoglobin based on the reasons by which HbA 1c is incorrectly measured.
We therefore measured HPLC-HbA 1c , IA-HbA 1c and GA values in patients with variant haemoglobin and aimed to classify variant forms of haemoglobin using the HbA 1c / GA results.
Subjects and methods

Subjects and controls
We investigated 20 different variant forms of haemoglobin from 43 subjects ( Table 1) . As previously reported, identification of variant haemoglobin was performed by electrospray ionization/mass spectrometry, tandem mass spectrometry and DNA analysis. 8 Eight patients with type 2 diabetes mellitus with stable glycaemic control were used as diabetic controls. All steps of this study, including DNA analysis, were approved by the Ethics Committees at Osaka Medical College and the study complied with the ethical guidelines of the Helsinki Declaration as revised in 2000. All subjects provided their written informed consent.
Laboratory measurements
HbA 1c was measured by HPLC (HPLC-HbA 1c ) using HA-8150 (Arkray Inc., Kyoto, Japan) 3 and by immunoassay (IA-HbA 1c ) using DCA-2000 (Bayer Diagnostics, Boston, MA, USA) 10 in these subjects. All these methods for HbA 1c were corrected as a National Glycohemoglobin Standardization Program (NGSP) equivalent value (%) calculated using the formula HbA 1c (%) ¼ HbA 1c (Japan Diabetes Society: JDS) (%) þ 0.4%, considering the relational expression of HbA 1c (JDS) (%) measured using previous Japanese standard substances and measurement methods and HbA 1c (NGSP).
11 Serum GA was measured by HPLC.
12
Since GA accurately reflects glycaemic control in patients with variant haemoglobin, we calculated the respective ratios of GA and HbA 1c and aimed to classify the variant forms of haemoglobin according to HbA 1c /GA. Variant forms of haemoglobin demonstrating low HPLC-HbA 1c / GA (,0.35) with normal IA-HbA 1c /GA (0.3 -0.5) were classified as C1. A further classification of a and b was used in order to differentiate between variant haemoglobin with abnormalities of the a chain and b chain in the haemoglobin gene. Other haemoglobin variants were classified as non-C1.
Statistical analysis
All data are shown as mean + SD. For statistical analysis, unpaired Student's t-test was used to compare two groups. P values of ,0.05 were considered to be statistically significant.
Results
According to the levels of HPLC-HbA 1c , IA-HbA 1c and GA, 20 variant forms of haemoglobin identified from 43 subjects in this study were classified as C1a (2 variant forms; Hb I-Interlaken and Hb J-Meerut), C1b (15 variant forms, n ¼ 38) and non-C1 (3 variant forms; Hb Himeji, Hb K-Woolwich and Hb Peterborough) ( Table 1 ). The majority of variant forms of haemoglobin were classified as C1b type. Among the 38 C1b patients, 10 patients (3 species) had diabetes mellitus while the other 28 patients (14 species) did not have diabetes mellitus.
We identified a positive correlation between GA and HPLC-HbA 15 We could not subcategorize non-C1 type since there were only three patients identified as non-C1. However, the HbA 1c /GA ratios of these patients with non-C1 type were different from each other. The HPLC-HbA 1c in patients with Hb K-Woolwich was known to be extremely high because the variant haemoglobin overlaps with HbA 1c on HPLC. 16 However, since HbA 1c measured by immunoassay reflects their state of glycaemic control, the LA-HbA 1c /GA was similar to that of the controls. Hb Himeji is reported to be increased glycation. 17, 18 Therefore, IA-HbA 1c in Hb Himeji was high, although HPLC-HbA 1c was low. Hb Peterbrough is known to be unstable haemoglobin. 19 Therefore, IA-HbA 1c in Hb Peterpough showed a low value. As a result, the non-C1 type of variant haemoglobin includes various forms and thus it is necessary to subclassify the non-C1 type in future after collecting data from many non-C1 patients. Fructosamine has been previously used as a measure of glycaemic control in patients with variant haemoglobin. 5 However, as fructosamine is expressed as the concentration of glycated protein, its measured values are affected by serum protein concentration. With distorted serum protein concentrations, fructosamine cannot accurately reflect glycaemic control. 20 GA is considered superior to fructosamine as a clinical marker of glycaemic control, as this value is expressed as a ratio of glycated albumin to total (glycated and non-glycated) albumin. 7 The present study is the first to examine GA concentrations in patients with variant haemoglobin systematically.
Several diseases showing abnormal HbA 1c values are known besides those involving variant haemoglobin. Haemolytic anaemia, liver cirrhosis, renal anaemia and iron deficiency anaemia under treatment show values that appear to be low, 21 while iron deficiency anaemia shows values that appear to be high. 22 Differentiating these diseases from variant haemoglobin is sometimes difficult. However, both HPLC and immunoassay yield similar HbA 1c results in the former, whereas both assays yield divergent HbA 1c results in all forms of variant haemoglobin ( Table 2) . As a result, variant haemoglobin and the other diseases can be differentiated in patients showing discrepancies between glycaemic control and HbA 1c values by measuring HbA 1c with HPLC and immunoassay and comparing both results.
In conclusion, variant forms of haemoglobin could be classified by measuring HbA 1c by HPLC and immunoassay and GA, and comparing the respective ratios of the three results. Differential diagnosis can also be made between variant haemoglobin and other conditions yielding abnormal HbA 1c values, using this approach.
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